JBF Capital, Inc. - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 13 filers reported holding HISTOGENICS CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JBF Capital, Inc. ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q3 2018$1,000
-50.0%
1,0000.0%0.00%
Q4 2017$2,0000.0%1,0000.0%0.00%
Q2 2017$2,0000.0%1,0000.0%0.00%
Q1 2017$2,0000.0%1,0000.0%0.00%
Q2 2016$2,0000.0%1,0000.0%0.00%
Q1 2016$2,000
-50.0%
1,0000.0%0.00%
Q4 2015$4,0000.0%1,0000.0%0.00%
-100.0%
Q3 2015$4,000
-33.3%
1,0000.0%0.00%0.0%
Q2 2015$6,000
-40.0%
1,0000.0%0.00%0.0%
Q1 2015$10,000
-9.1%
1,0000.0%0.00%
-50.0%
Q4 2014$11,0001,0000.00%
Other shareholders
HISTOGENICS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
Abingworth LLP 888,889$473,0000.28%
Archon Capital Management LLC 793,090$432,0000.17%
Sofinnova Investments, Inc. 2,077,040$1,132,0000.10%
Third Security, LLC 2,690,570$1,466,0000.10%
Perceptive Advisors 1,203,399$656,0000.02%
Endurant Capital Management LP 39,978$22,0000.01%
Palo Alto Investors LP 302,922$165,0000.01%
Virtu Financial LLC 213,352$117,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 296,099$161,0000.01%
Rossmore Private Capital 11,236$6,0000.00%
View complete list of HISTOGENICS CORP shareholders